A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.
- Published In:
- Diabetes, obesity & metabolism, 19(2), 216-227 (2017)
- Authors:
- Abd El Aziz, Mirna S, Kahle, Melanie, Meier, Juris J(6), Nauck, Michael A
- Database ID:
- RPEP-03194
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03194APA
Abd El Aziz, Mirna S; Kahle, Melanie; Meier, Juris J; Nauck, Michael A. (2017). A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.. Diabetes, obesity & metabolism, 19(2), 216-227. https://doi.org/10.1111/dom.12804
MLA
Abd El Aziz, Mirna S, et al. "A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.." Diabetes, 2017. https://doi.org/10.1111/dom.12804
RethinkPeptides
RethinkPeptides Research Database. "A meta-analysis comparing clinical effects of short- or long..." RPEP-03194. Retrieved from https://rethinkpeptides.com/research/abd-2017-a-metaanalysis-comparing-clinical
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.